Pamelor
NDC Package 0406-9918-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Pamelor is a medication used to treat mental/mood problems such as depression. Marketed by Mallinckrodt, Inc., this product is identified by NDC 0406-9918 and is authorized under FDA application NDA018012.

Identification & Billing

NDC Package Code
0406-9918-16
Package Description
473 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
00406991816

Clinical Specifications

Proprietary Name
Pamelor
Dosage Form
-
Usage Information
This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters) in the brain.

Regulatory & Marketing

Labeler Name
Mallinckrodt, Inc.
FDA Application #
NDA018012
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-03-2010
End Marketing Date
07-25-2012
Listing Expiration
07-25-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0406-9918-16 identifies a specific commercial package of 473 ml in 1 bottle of Pamelor, labeled by Mallinckrodt, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mallinckrodt, Inc. on August 03, 2010. The current certification is valid through July 25, 2012.

What are the primary indications for this medication?

This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters) in the brain.

How is this Mallinckrodt, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00406991816. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0406-9918-16
11-Digit CMS (5-4-2)
00406-9918-16

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.